TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/11/23 21:11 | 5/9/23 | SLRN | Acelyrin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Svoronos Dawn | CA | D | P.d | 270 | 18.00 | 0 | 15 | New | 15 | D | |||||||||||||||
5/18/22 16:43 | 5/16/22 | ADVM | Adverum Biotechnologies, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Svoronos Dawn | CA | D | P | 26 | 0.8526 | 0 | 30 | 150 | 50 | D | |||||||||||||||
4/1/21 20:21 | 3/31/21 | ADVM | Adverum Biotechnologies, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Svoronos Dawn | CA | D | P | 200 | 10.02 | 0 | 20 | New | 20 | D | |||||||||||||||
8/15/17 16:54 | 8/14/17 | XENE | Xenon Pharmaceuticals Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Svoronos Dawn | A1 | D | P | 141 | 2.82 | 0 | 50 | New | 50 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |